Latest News in the pharma Industry

Research & Development

FDA approves Blincyto to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia

FDA approves Blincyto to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia

12 Jul 2017

Blincyto is the first and only Bispecific T cell Engager (BiTE) immunotherapy to demonstrate superior overall survival versus standard of care chemotherapy.

Read more 
Erytech collaborates with Queen’s University to advance product candidate for rare metabolic disorders

Erytech collaborates with Queen’s University to advance product candidate for rare metabolic disorders

12 Jul 2017

The collaboration will leverage the expertise of Queen’s University and Erytech’s ERYCAPS platform technology.

Read more 
New data reinforce the effectiveness of Viberzi  to treat the symptoms associated with IBS-D

New data reinforce the effectiveness of Viberzi to treat the symptoms associated with IBS-D

11 Jul 2017

Viberzi proven safe and effective in patients who reported inadequate response to prior loperamide use.

Read more 
Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center announce cancer research collaboration

Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center announce cancer research collaboration

11 Jul 2017

Parties to optimize certain novel compounds that target cancer cell transcription and proliferation.

Read more 
Trial to identify breath biomarkers to improve the early detection and diagnosis of cancer

Trial to identify breath biomarkers to improve the early detection and diagnosis of cancer

10 Jul 2017

Owlstone Medical and Cancer Research UK initiate pan cancer clinical trial.

Read more 
Shire submits IND application to FDA for gene therapy candidate SHP654 for treatment of hemophilia A

Shire submits IND application to FDA for gene therapy candidate SHP654 for treatment of hemophilia A

9 Jul 2017

SHP654 aims to deliver sustained protection against bleeds for patients with hemophilia A.

Read more 
Almac Discovery granted Orphan Drug Designation for ALM201 programme in ovarian cancer

Almac Discovery granted Orphan Drug Designation for ALM201 programme in ovarian cancer

7 Jul 2017

ALM201 is a therapeutic peptide developed to mimic some of the properties of the naturally occurring protein FKBPL.

Read more 
Phase III study evaluating safety and efficacy of adjuvant Opdivo in resected melanoma patients meets primary endpoint

Phase III study evaluating safety and efficacy of adjuvant Opdivo in resected melanoma patients meets primary endpoint

6 Jul 2017

Opdivo demonstrates superior recurrence-free survival versus Yervoy in adjuvant setting in CheckMate -238.

Read more 
First patients treated in Phase I/II trial of  NOX-A12 combined with Keytruda in metastatic pancreatic and colorectal cancer

First patients treated in Phase I/II trial of NOX-A12 combined with Keytruda in metastatic pancreatic and colorectal cancer

4 Jul 2017

NOX-A12 has the potential to transform cancer types that are resistant to checkpoint inhibitor therapy into checkpoint inhibitor sensitive tumours

Read more 
Common antimicrobials help patients recover from MRSA abscesses

Common antimicrobials help patients recover from MRSA abscesses

3 Jul 2017

NIAID-funded trial counters current thinking about treatment effectiveness.

Read more 
Novartis receives EU approval for first-line use of Zykadia in ALK-positive advanced NSCLC

Novartis receives EU approval for first-line use of Zykadia in ALK-positive advanced NSCLC

29 Jun 2017

In ALK-positive advanced NSCLC patients, Zykadia demonstrated superior median progression-free survival compared with SOC chemotherapy with maintenance.

Read more 
Researchers develop microneedle patch for flu vaccination

Researchers develop microneedle patch for flu vaccination

28 Jun 2017

The patch can dramatically reduce the cost of vaccination, as self-administration can eliminate the need to have health workers oversee the process.

Read more